John F. Neylan

John F. Neylan has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Elicio Therapeutics, Inc. and Keryx Biopharmaceuticals Inc. Over a trading history stretching from 28 January 2016 to 20 December 2021, the count stands at 9 filings.

Every open-market trade on record is a sale: 8 sales worth €23k. Besides market trades, the filings include 1 share grant. In 2021 alone, the filings show no purchases and 8 sales.

On 21 December 2021 came the latest disclosure, an open-market sale for €834 in Elicio Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.